Skip to main content

Table 1 Expression fold changes of 84 AM genes in CD34+ cells from CR AML patients

From: Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy

Genes

chemoresistant

vs

control

chemosensitive vs

control

chemoresistant

vs

chemosensitive

Genes

chemoresistant

vs

control

chemosensitive

vs

control

chemoresistant

vs

chemosensitive

ABL1

1.05 (0.85)

-1.04 (1)

-1.11 (1)

CASP7

-2.08 (0.14)

-2 (0.03)

-1.26 (0.17)

AKT1

-1.55 (0.15)

-1.05 (0.87)

-1.79 (0.18)

CASP8

-15.74 (0.006)

-19.29 (0.04)

1.01 (1)

APAF1

1.35 (0.29)

2.66 (0.08)

-2.38 (0.007)

CASP9

-1.95 (0.20)

-1.46 (0.08)

-1.61 (0.09)

BAD

1.35 (0.26)

1.47 (0.20)

-1.32 (0.46)

CD27

-1.49 (0.24)

-2.33 (0.11)

1.29 (0.99)

BAG1

1.75 (0.34)

1.55 (0.47)

-1.07 (1)

CD40

-3.11 (0.02)

-4.89 (0.01)

1.3 (0.50)

BAG3

-41.26 (0.0004)

-76.11 (0.00009)

1.53 (1)

CD40LG

-16.3 (0.01)

-2.57 (0.04)

-7.67 (0.02)

BAG4

-2.34 (0.09)

-2.99 (0.08)

1.06 (1)

CD70

-10.31 (0.002)

-17.03 (0.01)

1.37 (0.62)

BAK1

-1.11 (1)

-1.26 (0.47)

-1.06 (1)

CFLAR

-51.86 (0.002)

-22.01 (0.003)

-2.85 (0.03)

BAX

1.43 (0.80)

1.31 (0.73)

-1.11 (1)

CIDEA

-15.74 (0.008)

-19.29 (0.009)

1.01 (1)

BCL10

3.09 (0.007)

3.01 (0.007)

1.01 (1)

CIDEB

1.26 (0.37)

2.55 (0.03)

-2.45 (0.001)

BCL2

2.15 (0.12)

1.9 (0.23)

-1.35 (0.30)

CRADD

-1.24 (0.18)

-1.77 (0.07)

1.18 (0.52)

BCL2A1

-5.19 (0.01)

-2.81 (0.02)

-2.23 (0.004)

DAPK1

-15.74 (0.0006)

-19.29 (0.0002)

1.01 (1)

BCL2L1

-3.5 (0.007)

1.06 (0.44)

-4.47 (0.005)

DFFA

3.11 (0.00008)

3.01 (0.00009)

1.01 (1)

BCL2L10

-15.74 (0.01)

-19.29 (0.02)

1.01 (1)

FADD

-5.02 (0.004)

-6.41 (0.004)

1.06 (1)

BCL2L11

1.36 (0.25)

1.38 (0.26)

-1.22 (0.72)

FAS

-7.19 (0.01)

-3.53 (0.04)

-2.46 (0.003)

BCL2L2

-1.25 (0.24)

-1.04(1)

-1.44 (0.21)

FASLG

-22.58 (0.005)

-4.32 (0.02)

-6.32 (0.01)

BCLAF1

3.12 (0.003)

3.04(0.002)

1.01 (1)

GADD45A

-2.09 (0.16)

-2.69 (0.22)

1.06 (1)

BFAR

3.01 (0.0006)

1.84(0.03)

1.01 (1)

HRK

-3.75 (0.01)

-6.11 (0.01)

1.35 (0.30)

BID

-1.03 (0.93)

1.16 (0.43)

-1.44 (0.21)

IGF1R

-2.29 (0.08)

-3.16 (0.07)

1.14 (1)

BIK

1.1 (1)

1.47 (0.34)

-1.61 (0.38)

LTA

-7.34 (0.05)

-4.72 (0.01)

-1.88 (0.12)

BIRC2

3.77 (0.006)

-7.26 (0.004)

22.63 (0.001)

LTBR

-1.38 (0.25)

-1.13 (0.47)

-1.47 (0.27)

BIRC3

-3.02 (0.001)

-10.13 (0.004)

2.77 (0.001)

MCL1

1.51 (0.33)

1.34 (0.46)

-1.07 (0.51)

BIRC4

-11.77 (0.0007)

-15.14 (0.0007)

1.06 (1)

NAIP

1.96 (0.13)

1.39 (0.34)

1.16 (1)

BIRC6

-1.08 (0.85)

1.04 (0.73)

-1.37 (0.18)

NOD1

-1.31 (0.36)

-1.09 (0.94)

-1.44 (0.75)

BIRC8

-17.71 (0.0005)

-21.71 (0.0002)

1.01 (1)

NOL3

-15.74 (0.001)

-10.34 (0.0003)

-1.84 (0.21)

BNIP1

-9.17 (0.0008)

-10.41 (0.001)

-1.06 (1)

PYCARD

1.12 (0.48)

1.79 (0.07)

-1.93 (0.05)

BNIP2

-8.15 (0.005)

-7.52 (0.007)

-1.31 (0.24)

RIPK2

-1.11 (0.21)

-1.69 (0.48)

1.26 (0.08)

BNIP3

-8.38 (0.02)

-9.71 (0.03)

-1.04 (1)

TNF

2.08 (0.18)

2.3 (0.31)

-1.34 (0.29)

BNIP3L

-3.75 (0.02)

-4.41 (0.01)

-1.03 (1)

TNFRSF10A

-6.13 (0.013)

-4.03 (0.01)

-1.84 (0.13)

BRAF

-1.09 (0.83)

-1.27 (0.15)

-1.04 (1)

TNFRSF10B

-5.72 (0.016)

-4.92 (0.02)

-1.4 (0.43)

CARD6

-15.74 (0.001)

-19.29 (0.0008)

1.01 (1)

TNFRSF11B

-15.74 (0.007)

-19.29 (0.007)

1.01 (1)

CARD8

-4.55 (0.01)

-3.76 (0.01)

-1.46 (0.19)

TNFRSF1A

2.42 (0.13)

1.65 (0.11)

1.21 (0.76)

CASP1

-1.35 (0.45)

1.06 (0.48)

-1.74 (0.01)

TNFRSF21

1.1 (0.29)

-1.48 (0.83)

1.35 (0.12)

CASP10

-5.12 (0.01)

-6.5 (0.012)

1.05 (1)

TNFRSF25

1.07 (1)

3.61 (0.03)

-4.06 (0.03)

CASP14

-25.4 (0.03)

-58.89 (0.0004)

1.92 (0.02)

TNFRSF9

-15.74 (0.03)

-18.38 (0.01)

-1.04 (1)

CASP2

1.05 (1)

1.1 (1)

-1.27 (1)

TNFSF10

-1.25 (0.12)

1.45 (0.08)

-2.2 (0.01)

CASP3

1.07 (1)

-1.13 (0.68)

-1.01 (1)

TNFSF8

-9.04 (0.007)

-10.7 (0.008)

-1.02 (1)

CASP4

-1.47 (0.08)

-1.57 (0.09)

-1.13 (0.72)

TP53

1.27 (0.20)

1.2 (0.23)

-1.14 (0.70)

CASP5

-12.27 (0.002)

-11.71 (0.002)

-1.27 (0.16)

TP53BP2

-15.74 (0.02)

-19.29 (0.003)

1.01 (1)

CASP6

1.2 (0.34)

1.2 (0.43)

-1.21 (0.99)

TP73

-53.32 (0.006)

-48.5 (0.006)

-1.33 (0.70)

  1. Fold changes of 84 AM gene expression, according to the alternative version of 2-ΔΔCT method, for three different comparisons between phenotypic classes: chemoresistant vs control; chemosensitive vs control; chemoresistant vs chemosensitive. When the RQ is ≥1, we reported the same RQ number (positive fold change); when RQ is < 1, we reported -1/RQ: (negative fold change). We considered as up regulated or down regulated those genes with fold change ≥2 and ≤ -2, respectively. Genes with a fold change between 2 and -2 are considered as unchanged. Adjusted Bonferroni p-value is reported between brackets.